Structure Therapeutics Inc - American Depositary Shares — Statistiche Finanziarie Trimestrali (NASDAQ:GPCR) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -36.47 M-52.23 M-54.56 M-51 M-64.42 M -222.2 M Flussi di cassa derivanti dalle attività di investimento 33.23 M34.03 M48.94 M-49.32 M56.14 M 89.8 M Liquidità derivante dalle attività di finanziamento 615 K809 K517 K56.2 M704.99 M 762.52 M Liquidità libera -36.48 M-52.54 M-54.79 M-52.57 M-65.91 M -225.81 M

Notizie

Leerink conferma rating Outperform su Structure Therapeutics

Structure Therapeutics nomina Matthew Lang COO e consulente legale

Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?

Structure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy

Structure Therapeutics: A High-Risk, High-Reward Bet On The Next GLP-1 Blockbuster (GPCR)

Wolfe Research avvia la copertura su Structure Therapeutics con rating Peerperform

NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?

Eli Lilly's Experimental Drug Retatrutide Delivers Strong Weight Loss In Late-Stage Trial

Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum?

BMO raises Structure Therapeutics stock price target on obesity drug data

Structure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition Target (GPCR)

H.C. Wainwright riduce il target su Structure Therapeutics